Attitudes to target behaviours | Control | Intervention | Treatment effect | |
---|---|---|---|---|
Barriers | Â | Â | Â | Â |
Diet | Baseline | 2.49 (0.58) | 2.37 (0.61) | Â |
 | 28 weeks | 2.45 (0.58) | 2.14 (0.68) | −0.18 (−0.35 to 0.00) |
Physical activity | Baseline | 2.64 (0.55) | 2.48 (0.63) | Â |
 | 28 weeks | 2.47 (0.50) | 2.20 (0.61) | −0.20 (−0.37 to −0.03) |
Perceived benefits | Â | Â | Â | Â |
Diet | Baseline | 3.75 (0.72) | 3.80 (0.64) | Â |
 | 28 weeks | 3.79 (0.67) | 3.97 (0.80) | 0.13 (−0.10 to 0.36) |
Physical activity | Baseline | 3.94 (0.70) | 4.04 (0.54) | Â |
 | 28 weeks | 3.84 (0.60) | 4.06 (0.69) | 0.17 (−0.04 to 0.38) |
Confidence | Â | Â | Â | Â |
Diet | Baseline | 3.78 (0.75) | 3.84 (0.64) | Â |
 | 28 weeks | 3.71 (0.72) | 3.85 (0.81) | 0.11 (−0.15 to 0.37) |
Physical activity | Baseline | 3.76 (0.88) | 3.92 (0.81) | Â |
 | 28 weeks | 3.77 (0.88) | 3.81 (1.06) | −0.05 (−0.40 to 0.30) |
Quality of life (EQ-5D) | Â | Control | Intervention | Treatment effect |
n: baseline, 28 weeks |  | n = 87, 75 | n = 94, 80 |  |
Numbers reporting problems | Â | Â | Â | |
Mobility | Baseline | 10 (11%) | 11 (12%) | Â |
 | 28 weeks | 21 (28%) | 25 (31%) | 4% (−10 to 18) |
Change (all women) | Â | Â | 19% (11 to 27) | |
Self-care | Baseline | 1 (1%) | 0 (0%) | Â |
 | 28 weeks | 3 (4%) | 3 (4%) | −0.3% (−6 to 6) |
Change (all women) | Â | Â | 4% (0 to 8) | |
Usual activities | Baseline | 16 (18%) | 13 (14%) | Â |
 | 28 weeks | 26 (34%) | 26 (33%) | −1% (−15 to 12) |
Change (all women) | Â | Â | 16% ( 8 to 24) | |
Pain & discomfort | Baseline | 38 (43%) | 34 (36Â %) | Â |
 | 28 weeks | 45 (60%) | 54 (67%) | 10% (−1 to 22) |
Change (all women) | Â | Â | 25% (17 to 34) | |
Anxiety & depression | Baseline | 22 (25%) | 20 (21%) | Â |
 | 28 weeks | 11 (15%) | 17 (21%) | 5% (−4 to 15) |
Change (all women) |  |  | −6% (−14 to 1) | |
TTO score | Baseline | 0.85 (0.18) | 0.88 (0.14) | Â |
 | 28 weeks | 0.79 (0.24) | 0.79 (0.16) | −0.03 (−0.07 to 0.02) |
Change (all women) |  |  | −0.08 (−0.10 to −0.06) | |
VAS (0 to 100) | Baseline | 76 (20) | 76 (21) | Â |
 | 28 weeks | 75 (21) | 78 (21) | 4 (−3 to 10) |
Change (all women) |  |  | −2 (−6 to 2) | |
EPDS | Â | Â | Â | Â |
Total | Baseline | 7.1 (4.6) | 7.4 (4.5) | Â |
 | 28 weeks | 6.9 (4.2) | 7.1 (5.2) | 0.1 (−1.1 to 1.3) |
Total Score > 9 | Baseline | 25 (29%) | 28 (30%) |  |
 | 28 weeks | 17 (23%) | 21 (26%) | 1% (−9 to 11) |
Total score > 12 | Baseline | 9 (10%) | 10 (11%) |  |
 | 28 weeks | 6 (8%) | 14 (18%) | 7% (−1% to 16) |